Document Detail


Posttreatment but not pretreatment with selective beta-adrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia.
MedLine Citation:
PMID:  20357154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: beta-Adrenoreceptor antagonists provide neuroprotection against focal cerebral ischemia, but the effects of these antagonists on experimental global cerebral ischemia are unknown. That is, the effect of beta-adrenoreceptor antagonism in vulnerable brain regions after ischemic insult has not been examined. Therefore, we investigated the neuroprotective effects of preischemic or postischemic administration of propranolol (a nonselective beta-adrenoreceptor antagonist), esmolol, and landiolol (selective beta-adrenoreceptor 1 antagonists) against forebrain ischemia in rats. METHODS: IV administration of saline 10 microL . h(-1), propranolol 100 microg . kg(-1) . min(-1), esmolol 200 microg . kg(-1) . min(-1), or landiolol 50 microg . kg(-1) . min(-1) in male Sprague-Dawley rats was started 30 minutes before or 60 minutes after 8-minute bilateral carotid artery occlusion combined with hypotension (35 mm Hg) under isoflurane (1.5%) anesthesia. All drugs were administered continuously until 5 days after reperfusion, and the animals were evaluated neurologically and histologically after this 5-day period. RESULTS: Preischemic treatment with propranolol, esmolol, or landiolol failed to provide neuroprotection against forebrain ischemia in the hippocampus. Rats treated with propranolol tended to have a worse score for motor activity and a higher mortality rate (up to 64%), but the differences with other groups were not statistically significant. Postischemic treatment with esmolol and landiolol, but not with propranolol, reduced neuronal injury after forebrain ischemia. However, motor activity did not differ among rats treated postischemically with any of the beta-adrenoreceptor antagonists or saline. CONCLUSIONS: Postischemic treatment with esmolol and landiolol provided neuroprotection in the hippocampus in rats subjected to bilateral carotid artery occlusion combined with hemorrhagic shock, whereas treatment with propranolol failed to show neuroprotection. We suggest that concomitant beta-blockade and shock might work as a systemic depressant, rather than a neuroprotectant, resulting in exacerbation of cerebral ischemia.
Authors:
Masato Iwata; Satoki Inoue; Masahiko Kawaguchi; Mitsutoshi Nakamura; Noboru Konishi; Hitoshi Furuya
Related Documents :
15448524 - Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebra...
10773194 - Electrical responses in hippocampal slices after prolonged global ischemia: effects of ...
2864754 - Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-para-tyro...
12164544 - Lipid peroxidation in rat brain during focal cerebral ischemia: prevention of malondial...
14716104 - Zinc prevention of electromagnetically induced damage to rat testicle and kidney tissues.
16499564 - Therapeutic value of melatonin in an experimental model of liver injury and regeneration.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  110     ISSN:  1526-7598     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-01     Completed Date:  2010-04-23     Revised Date:  2010-05-28    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1126-32     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology, Nara Medical University, Nara 634-8522, Japan. seninoue@naramed-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology*
Animals
Blood Pressure / drug effects
Carotid Arteries / physiology
Executive Function / drug effects
Heart Rate / drug effects
Hippocampus / pathology*
Infusion Pumps, Implantable
Ischemic Attack, Transient / mortality,  pathology*
Male
Neuroprotective Agents*
Rats
Rats, Sprague-Dawley
Receptors, Adrenergic, beta-1 / agonists*
Reperfusion Injury / pathology,  prevention & control
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Neuroprotective Agents; 0/Receptors, Adrenergic, beta-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accuracy of preoperative electrocardiographic and chest radiographic screening for prediction of lef...
Next Document:  Influence of procedure classification on process variability and parameter uncertainty of surgical c...